Navigation Links
Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
Date:1/30/2008

SOMERSET, N.J., Jan. 30 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that 311 evaluable events (patient deaths) have occurred in the Phase IIIb clinical trial of its lead compound, ONCONASE, for the treatment of patients with unresectable malignant mesothelioma. Enrollment in the ONCONASE Phase IIIb clinical trial was closed on Sept. 30, 2007. A total of 428 patients were enrolled in the trial.

In accordance with the statistical plan for the study, the company must wait until 316 evaluable events have occurred to conduct the formal statistical analysis required to complete the final sections of the ONCONASE rolling New Drug Application (NDA). To be considered evaluable, patients must meet all of the eligibility requirements for the study and receive at least one dose of study drug.

About ONCONASE(R)

ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. ONCONASE triggers apoptosis, the natural death of cells, via multiple molecular mechanisms of action.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alface
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
7. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
8. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
9. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
10. BioCryst Updates Peramivir Clinical Development Plan
11. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... N.Y. and HAMBURG, Germany , Aug. 21, 2014 ... is collaborating with Deutsches Elektronen-Synchrotron ( DESY ), a ... , to speed up management and storage of massive ... and Analytics architecture based on IBM software defined ... of data at peak performance and help scientists worldwide ...
(Date:8/21/2014)... 2014 BreedIT Corp., (OTCQB: ... exclusive worldwide license holder and distributor of highly ... researchers, today is pleased to announce the formation ... Ltd, a leading Israeli medical Cannabis breeder. ... new breeds of medical Cannabis to meet the ...
(Date:8/21/2014)... N.J. , Aug. 21, 2014  Armada ... group purchasing organization (GPO), is pleased to announce ... collaborate on a host of innovative specialty pharmacy ... Aurora deliver enhanced therapy management services to specialty ... (OTM) system. Aurora will use the ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3
... 5 Salmonella bacteria is normally very toxic ... to prevent it from causing illness and instead kill cancer ... – a medical oddity first observed in the 1890s, but ... non toxic Salmonella variations. Genetically-modified ...
... 5 Generex Biotechnology Corporation (Nasdaq: GNBT ... in a letter to shareholders from Interim President and ... for growth. The letter to shareholders reads as follows: ... at Generex, the management team has been working diligently ...
Cached Medicine Technology:Botanic Oil Innovations Funds Human Clinical Study Using Non-Toxic Salmonella as Cancer Medicine 2Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 2Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 3Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 4Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 5Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 6Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 7Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 8
(Date:8/22/2014)... Washington, DC (PRWEB) August 22, 2014 ... a little easier in the coming year for four ... from the National League for Nursing Foundation for ... candidates – will share $28,000, $10,000 more than in ... Margaret Ann Kerr Endowment and Elizabeth Isaac Marcil Endowment ...
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... by Dr. Sen and Dr. Samantha Pearson to help ... contacts, and avoid corrective vision surgery by instead improving ... Michaels, prompting an investigative review. , “There’s a ... of dollars in revenue each year—it’s because people just ...
(Date:8/22/2014)... August 22, 2014 Advancements in ... some clinical applications due to their cost-effectiveness, non-invasiveness, ... innovations in ultrasound, such as the evolution of ... to keep the market moving throughout 2014 and ... can enhance not only the point-of-care (POC) testing ...
(Date:8/22/2014)... New York, New York (PRWEB) August 22, 2014 ... ) continue to be filed in U.S. courts ... cardiovascular events due to their use of prescription ... to court documents, a new claim was filed ... California man who allegedly suffered life-threatening heart issues ...
(Date:8/22/2014)... Eagerly embracing intended parents around the ... now offers the top male infertility programs — run ... fertility network of IVFinMexico.com continues to shape ... care, female and male infertility, advanced research and education. ... so eminently set by company CEO and Founder Tolga ...
Breaking Medicine News(10 mins):Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4
... the development of vascular diseases may also contribute to ... access in dialysis patients, according to a study appearing ... the American Society of Nephrology (JASN). "Our ... may contribute to the relatively poor outcomes regarding the ...
... HealthDay Reporter , WEDNESDAY, Dec. 22 (HealthDay News) -- ... as the "stroke belt" eat twice as much fried fish ... according to a new study looking at regional and ethnic ... The stroke belt, with more deaths from stroke than ...
... , WEDNESDAY, Dec. 22 (HealthDay News) -- A gene ... patients with glioblastoma brain cancer has been identified by ... as NFKBIA -- contributes to tumor development, promotes resistance ... of patients with glioblastoma, the most common and deadly ...
... , WEDNESDAY, Dec. 22 (HealthDay News) -- ... the hospital increases the risk of complications from infections ... new study. U.S. researchers looked at patients who ... surgery: 87,318 coronary artery bypass graft (CABG) procedures; 46,728 ...
... sex are you? Sex in mammals is genetically ... have one X and one Y chromosome. However, some individuals ... a condition known as XX male sex reversal. A team ... has now determined that overexpression of the Sox3 gene in ...
... On December 14-15, 2010, the U.S. Food and Drug Administration ... that may affect the regulation of dental amalgam. At the ... the FDA conduct further review of the material,s safety. ... Final Rule ( http://bit.ly/FDA2009FinalRule ) from the FDA that reclassified ...
Cached Medicine News:Health News:Why does dialysis fail? 2Health News:Too Much Fried Fish Might Help Make South the 'Stroke Belt' 2Health News:Too Much Fried Fish Might Help Make South the 'Stroke Belt' 3Health News:Gene Mutation Found in One of Four Cases of Deadly Brain Cancers 2Health News:Timely Surgery Appears to Cut Infection Risk, Costs 2Health News:JCI table of contents: Dec. 22, 2010 2Health News:JCI table of contents: Dec. 22, 2010 3Health News:JCI table of contents: Dec. 22, 2010 4Health News:JCI table of contents: Dec. 22, 2010 5Health News:JCI table of contents: Dec. 22, 2010 6Health News:JCI table of contents: Dec. 22, 2010 7Health News:JCI table of contents: Dec. 22, 2010 8Health News:JCI table of contents: Dec. 22, 2010 9Health News:JCI table of contents: Dec. 22, 2010 10Health News:JCI table of contents: Dec. 22, 2010 11Health News:JCI table of contents: Dec. 22, 2010 12Health News:AADR testifies to the FDA advisory panel on dental amalgam 2
300 L, Bulk Recommended for 250 and 300 L pipettes....
... PerkinElmer manufactures Robotic Certified Tips for ... dispensing systems. Manufactured with the highest quality, ... to provide unparalleled accuracy in high throughput ... with a volume range from 0.5 L ...
MBP's 200 ul large orifice tip is perfect for handling fragile cells, viscous samples, and genomic DNA....
This extra long 180 ul pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container....
Medicine Products: